Rivastigmine hydrogentartrate
- Level
- Commodity
- Parent
- 51151500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51151550This classification denotes an acetylcholinesterase inhibitor with the molecular formula C14H22N2O2.C4H6O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9IY2357JPE, chemically known as carbamic acid, n-ethyl-n-methyl-, 3-((1s)-1-(dimethylamino)ethyl)phenyl ester, (2r,3r)-2,3-dihydroxybutanedioate (1:1), but more generally known as rivastigmine hydrogentartrate, which bears US NIH Compound Identifier 77990. European Medicines Agency schedules rivastigmine hydrogentartrate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10345MIG. Most nations, for tariff purposes, schedule rivastigmine hydrogentartrate under HS 29242995. SMILES: CCN(C)C(=O)OC1CCCC(C1)[C@H](C)N(C)C.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O.
Same parent
Under 51151500 · 44Activities that produce or sell this
KBLI · 8Inherited from family 51150000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.